Share Twitter LinkedIn Facebook Email Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology discusses  Update in IO Neoadjuvant (Preoperative) Trials at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia
Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber Genitourinary 3 Mins Read
Renal Cell Carcinoma TiNivo-2 Study: Patient-Reported Outcomes in Treatment Post-ICI Kidney 3 Mins Read
VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC Kidney 4 Mins Read